Tchaikapharma High Quality Medicines AD reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was BGN 12.78 million compared to BGN 13.39 million a year ago. Revenue was BGN 12.83 million compared to BGN 13.39 million a year ago.

Net income was BGN 1.88 million compared to BGN 3.05 million a year ago. Basic earnings per share from continuing operations was BGN 0.02 compared to BGN 0.04 a year ago.